ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,029Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 783

$774K Total Retail Price of All Prescriptions

Rank: 106 out of 783

408 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 408 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 408 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

1% of this provider’s 10,585 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
SIMVASTATIN 673 588 1 3
LEVOTHYROXINE SODIUM 536 473 2 1
LISINOPRIL 501 438 3 4
OMEPRAZOLE 439 319 4 6
HYDROCODONE-ACETAMINOPHEN 385 301 S3 5 2
AMLODIPINE BESYLATE 356 327 6 5
METOPROLOL SUCCINATE 330 298 7 13
PRAVASTATIN SODIUM 282 243 8 14
FUROSEMIDE 269 232 9 7
ATORVASTATIN CALCIUM 264 213 10 11
METFORMIN HCL ER 230 181 11 64
METFORMIN HCL 197 153 12 8
GLIMEPIRIDE 192 187 13 34
FENOFIBRATE 184 107 14 66
CARVEDILOL 158 141 15 21
GABAPENTIN 148 115 16 15
NEXIUM 140 93 17 28
ATENOLOL 134 134 18 17
LOSARTAN POTASSIUM 126 123 19 18
ZOLPIDEM TARTRATE 123 99 20 23
WARFARIN SODIUM 123 112 20 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 108 22 33
METOPROLOL TARTRATE 115 100 23 9
CITALOPRAM HBR 113 89 24 19
CRESTOR 108 103 25 27
TAMSULOSIN HCL 104 77 26 26
CLOPIDOGREL 102 83 27 29
ESCITALOPRAM OXALATE 101 76 28 54
POTASSIUM CHLORIDE 99 89 29 16
HYDROCHLOROTHIAZIDE 99 82 29 12
PREDNISONE 98 86 31 36
MELOXICAM 97 85 32 37
SERTRALINE HCL 97 80 32 22
FLUOXETINE HCL 86 46 34 45
JANUVIA 86 86 34 73
TRAZODONE HCL 85 52 36 39
TRAMADOL HCL 83 83 37 20
ISOSORBIDE MONONITRATE ER 81 70 38 40
FLUTICASONE PROPIONATE 80 63 39 46
CYMBALTA 79 27 40 35
LEVEMIR FLEXPEN 78 75 41 155
DIOVAN 76 74 42 49
PREMARIN 75 71 R 43 176
LIPITOR 72 60 44 114
MORPHINE SULFATE ER 71 39 S2 45 107
FINASTERIDE 71 59 45 127
NAMENDA 70 70 47 32
LYRICA 70 48 47 98
PLAVIX 69 60 49 51
TIZANIDINE HCL 65 37 50 133
ONGLYZA 63 55 51 240
LANTUS 62 62 52 38
ALENDRONATE SODIUM 60 47 53 25
DOXAZOSIN MESYLATE 60 60 53 87
BYSTOLIC 59 36 55 99
OXYCODONE HCL-ACETAMINOPHEN 59 24 S2 55 86
PRAMIPEXOLE DIHYDROCHLORIDE 59 51 55 147
SINGULAIR 58 44 58 90
PROAIR HFA 58 33 58 56
TOPIRAMATE 57 25 60 152
KLOR-CON M20 56 42 61 48
CELEBREX 56 56 61 93
METHYLPREDNISOLONE 56 44 61 138
OXYCODONE-ACETAMINOPHEN 55 37 S2 64 76
SPIRIVA 53 23 65 59
JANUMET 52 52 66 217
PROPRANOLOL HCL 50 43 67 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 9, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.